We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALRN market cap is 18.66M. The company's latest EPS is USD -3.2201 and P/E is -1.17.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.48M | -4.7M | -5.01M | -1.99M | -1.98M |
Net Income | -6.37M | -4.55M | -4.78M | -1.79M | -1.83M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -29.96M | -20.5M | -26.61M | -27.65M | -16.28M |
Net Income | -29.37M | -21.16M | -26.16M | -27.33M | -15.73M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 27.23M | 22.01M | 17.16M | 13.99M | 12.82M |
Total Liabilities | 4.54M | 3.38M | 2.88M | 1.2M | 1.62M |
Total Equity | 22.7M | 18.62M | 14.27M | 12.79M | 11.2M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 26.47M | 16.34M | 48.48M | 22.01M | 106.01M |
Total Liabilities | 10.43M | 4.18M | 4.58M | 3.38M | 7.71M |
Total Equity | 16.05M | 12.16M | 43.9M | 18.62M | 98.3M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.46M | -24.87M | -4.66M | -7.78M | -9.42M |
Investing | 21.7M | 26.46M | 7.25M | 15.75M | 16.29M |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.47M | -20.48M | -23.75M | -24.87M | -19.81M |
Investing | -2.81M | 6.41M | -35.92M | 26.46M | 16.2M |
Financing | 23.96M | 15.8M | 55.66M | N/A | 15.79M |
Market Cap | 18.66M |
Price to Earnings Ratio | -1.17 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.06 |
Price to Book Ratio | 0.19 |
Dividend Yield | - |
Shares Outstanding | 4.89M |
Average Volume (1 week) | 225.73k |
Average Volume (1 Month) | 189.72k |
52 Week Change | 169.01% |
52 Week High | 7.42 |
52 Week Low | 1.01 |
Spread (Intraday) | 0.59 (14.43%) |
Company Name | Aileron Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aileronrx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions